Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

456 ARTÍCULOS , VIENDO DEL 106 AL 120

Measurement of aggressive behaviors in dementia: comparison of the physical aggression subscales of the Cohen-Mansfield Agitation Inventory and the Ryden Aggression Scale

Whall AL, Kim H, Colling KB, Hong GR, DeCicco B, Antonakos C.

Res Gerontol Nurs. 2013 Jul;6(3):171-7. doi: 10.3928/19404921-20130321-01. Epub 2013 Mar 28.

Risk factors for β-amyloid deposition in healthy aging: vascular and genetic effects

Rodrigue KM, Rieck JR, Kennedy KM, Devous MD Sr, Diaz-Arrastia R, Park DC.

JAMA Neurol. 2013 May;70(5):600-6. doi: 10.1001/jamaneurol.2013.1342.

Test Your Memory (TYM) as a screening instrument in clinical practice - the Polish validation study

Szczesniak D, Wojtynska R, Rymaszewska J.

Aging Ment Health. 2013;17(7):863-8. doi: 10.1080/13607863.2013.784957. Epub 2013 Apr 5.

Nonpharmacologic treatment and prevention strategies for dementia

Yaffe K, Hoang T.

Continuum (Minneap Minn). 2013 Apr;19(2 Dementia):372-81. doi: 10.1212/01.CON.0000429178.14354.67.

Incorporating new diagnostic schemas, genetics, and proteinopathy into the evaluation of frontotemporal degeneration

Chow TW, Alobaidy AA.

Continuum (Minneap Minn). 2013 Apr;19(2 Dementia):438-56. doi: 10.1212/01.CON.0000429173.35439.9c.

"Will I get Alzheimer disease?" when cognitively normal patients ask to be tested for Alzheimer disease

Snider BJ, Buckles VD.

Continuum (Minneap Minn). 2013 Apr;19(2 Dementia):470-4. doi: 10.1212/01.CON.0000429171.50686.07.

Genetic testing for early-onset Alzheimer disease

Tsao JW.

Continuum (Minneap Minn). 2013 Apr;19(2 Dementia):475-9. doi: 10.1212/01.CON.0000429170.50686.4e.

Patient management problem

Pierce A.

Continuum (Minneap Minn). 2013 Apr;19(2 Dementia):519-37. doi: 10.1212/01.CON.0000429166.97320.81.

Under-provision of medical care for vascular diseases for people with dementia in primary care: a cross-sectional review

Connolly A, Campbell S, Gaehl E, Iliffe S, Drake R, Morris J, Martin H, Purandare N.

Br J Gen Pract. 2013 Feb;63(607):e88-96. doi: 10.3399/bjgp13X663046.

Predictors of progression from mild cognitive impairment to dementia in the placebo-arm of a clinical trial population

Prins ND, van der Flier WM, Brashear HR, Knol DL, van de Pol LA, Barkhof F, Scheltens P.

J Alzheimers Dis. 2013;36(1):79-85. doi: 10.3233/JAD-122233.

[Assessment of mild cognitive impairment and dementia in epidemiologic studies. An overview on the current state of research in Germany]

Then FS, Luck T, Jacobi F, Berger K, Weyerer S, Grabe HJ, Busch MA, Wagner M, Riedel-Heller SG.

Psychiatr Prax. 2013 May;40(4):183-91. doi: 10.1055/s-0033-1343138. Epub 2013 Apr 5.

Chronic obstructive pulmonary disease and asthma and the risk of mild cognitive impairment and dementia: a population based CAIDE study

Rusanen M, Ngandu T, Laatikainen T, Tuomilehto J, Soininen H, Kivipelto M.

Curr Alzheimer Res. 2013 Jun;10(5):549-55. doi: 10.2174/1567205011310050011.

Psychosis of Alzheimer disease: prevalence, incidence, persistence, risk factors, and mortality

Vilalta-Franch J, López-Pousa S, Calvó-Perxas L, Garre-Olmo J.

Am J Geriatr Psychiatry. 2013 Nov;21(11):1135-43. doi: 10.1016/j.jagp.2013.01.051. Epub 2013 Feb 6.

Does personality affect risk for dementia? A systematic review and meta-analysis

Low LF, Harrison F, Lackersteen SM.

Am J Geriatr Psychiatry. 2013 Aug;21(8):713-28. doi: 10.1016/j.jagp.2012.08.004. Epub 2013 Feb 6.

Sundowning syndrome: a possible marker of frailty in Alzheimer's disease?

Ferrazzoli D, Sica F, Sancesario G.

CNS Neurol Disord Drug Targets. 2013 Jun;12(4):525-8. doi: 10.2174/18715273113129990065.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias